These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1675317)

  • 1. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.
    Lee HH; Swanson P; Rosenblatt JD; Chen IS; Sherwood WC; Smith DE; Tegtmeier GE; Fernando LP; Fang CT; Osame M
    Lancet; 1991 Jun; 337(8755):1435-9. PubMed ID: 1675317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
    Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
    Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
    San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
    J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
    Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
    Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
    Blejer JL; Saguier MC; Salamone HJ; Carreras LA
    Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
    Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
    Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina].
    Brun RO; Astarloa L; Salomon HE; Biglione MM
    Medicina (B Aires); 2004; 64(2):125-8. PubMed ID: 15628298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
    Chang YB; Kaidarova Z; Hindes D; Bravo M; Kiely N; Kamel H; Dubay D; Hoose B; Murphy EL
    J Infect Dis; 2014 Feb; 209(4):523-31. PubMed ID: 24068702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
    Dumas M; Houinato D; Verdier M; Zohoun T; Josse R; Bonis J; Zohoun I; Massougbodji A; Denis F
    AIDS Res Hum Retroviruses; 1991 May; 7(5):447-51. PubMed ID: 1873079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human T-cell lymphotropic virus testing of blood donors in Norway: a cost-effect model.
    Stigum H; Magnus P; Samdal HH; Nord E
    Int J Epidemiol; 2000 Dec; 29(6):1076-84. PubMed ID: 11101551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Seroprevalence of human T cell lymphotropic virus infection and associated factors of risk in blood donors of Rio Branco city, AC, Brazil (1998-2001)].
    Colin DD; Alcântara Júnior LC; Santos FL; Uchôa R; Tavares-Neto J
    Rev Soc Bras Med Trop; 2003; 36(6):677-83. PubMed ID: 15049106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and demographic characteristics of HTLV-I among blood donors in Taiwan: 1996-1999.
    Lu SC; Kao CL; Chin LT; Chen JW; Yang CM; Chang JH; Hsu SC; Chang AC; Chen BH
    Int J Hematol; 2001 Oct; 74(3):333-7. PubMed ID: 11721972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
    Lee YH; Lu CT; Feng IJ; Hung CM
    Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
    Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. The HTLV European Research Network.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):68-77. PubMed ID: 8797688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
    Kumar H; Gupta PK
    Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
    Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
    Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to human T-lymphotropic virus types I and II in volunteer blood donors and high-risk groups in northwestern Greece.
    Dalekos GN; Zervou E; Karabini F; Elisaf M; Bourantas K; Siamopoulos KC
    Transfusion; 1995 Jun; 35(6):503-6. PubMed ID: 7770902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.